Oxford BioDynamics Plc (LON: OBD), a biotechnology company focused on the discovery and development of biomarkers based on regulatory 3D genome architecture, for use within the pharmaceutical and biotechnology industry, today announced that copies of its annual report and accounts for the year ended 30 September 2019 (incorporating the Notice of Annual General Meeting) have been posted to shareholders. An electronic copy of the Annual Report will be available on its website at www.oxfordbiodynamics.com, within the Investor Relations section.
Notice of Annual General Meeting
Oxford BioDynamics’s Annual General Meeting will be held at The Kloppenberg Room, Cohen Quad, Exeter College, Walton Street, Oxford, OX1 2HE, on 20 March 2020 at 11.00 am.
